176 related articles for article (PubMed ID: 7789442)
1. A comparison of the behavioural effects of embryonic nigral grafts in the caudate nucleus and in the putamen of marmosets with unilateral 6-OHDA lesions.
Annett LE; Torres EM; Ridley RM; Baker HF; Dunnett SB
Exp Brain Res; 1995; 103(3):355-71. PubMed ID: 7789442
[TBL] [Abstract][Full Text] [Related]
2. Behavioral assessment of the effects of embryonic nigral grafts in marmosets with unilateral 6-OHDA lesions of the nigrostriatal pathway.
Annett LE; Martel FL; Rogers DC; Ridley RM; Baker HF; Dunnett SB
Exp Neurol; 1994 Feb; 125(2):228-46. PubMed ID: 7906227
[TBL] [Abstract][Full Text] [Related]
3. Survival of nigral grafts within the striatum of marmosets with 6-OHDA lesions depends critically on donor embryo age.
Annett LE; Torres EM; Clarke DJ; Ishida Y; Barker RA; Ridley RM; Baker HF; Dunnett SB
Cell Transplant; 1997; 6(6):557-69. PubMed ID: 9440865
[TBL] [Abstract][Full Text] [Related]
4. Behavioural analysis of unilateral monoamine depletion in the marmoset.
Annett LE; Rogers DC; Hernandez TD; Dunnett SB
Brain; 1992 Jun; 115 ( Pt 3)():825-56. PubMed ID: 1352726
[TBL] [Abstract][Full Text] [Related]
5. Restoration of complex sensorimotor behavior and skilled forelimb use by a modified nigral cell suspension transplantation approach in the rat Parkinson model.
Nikkhah G; Duan WM; Knappe U; Jödicke A; Björklund A
Neuroscience; 1993 Sep; 56(1):33-43. PubMed ID: 8232915
[TBL] [Abstract][Full Text] [Related]
6. Dopaminergic grafts implanted into the neonatal or adult striatum: comparative effects on rotation and paw reaching deficits induced by subsequent unilateral nigrostriatal lesions in adulthood.
Abrous DN; Torres EM; Dunnett SB
Neuroscience; 1993 Jun; 54(3):657-68. PubMed ID: 8332254
[TBL] [Abstract][Full Text] [Related]
7. Behavioural recovery following transplantation of substantia nigra in rats subjected to 6-OHDA lesions of the nigrostriatal pathway. I. Unilateral lesions.
Dunnett SB; Björklund A; Stenevi U; Iversen SD
Brain Res; 1981 Jun; 215(1-2):147-61. PubMed ID: 7260584
[TBL] [Abstract][Full Text] [Related]
8. Behavioural recovery following transplantation of substantia nigra in rats subjected to 6-OHDA lesions of the nigrostriatal pathway. II. Bilateral lesions.
Dunnett SB; Björklund A; Stenevi U; Iversen SD
Brain Res; 1981 Dec; 229(2):457-70. PubMed ID: 6796197
[TBL] [Abstract][Full Text] [Related]
9. Behavioural effects of subthalamic nucleus lesions in the hemiparkinsonian marmoset (Callithrix jacchus).
Henderson JM; Annett LE; Torres EM; Dunnett SB
Eur J Neurosci; 1998 Feb; 10(2):689-98. PubMed ID: 9749730
[TBL] [Abstract][Full Text] [Related]
10. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
[TBL] [Abstract][Full Text] [Related]
11. Foetal nigral cell suspension grafts influence dopamine release in the non-grafted side in the 6-hydroxydopamine rat model of Parkinson's disease: in vivo voltammetric data.
Earl CD; Reum T; Xie JX; Sautter J; Kupsch A; Oertel WH; Morgenstern R
Exp Brain Res; 1996 Apr; 109(1):179-84. PubMed ID: 8740224
[TBL] [Abstract][Full Text] [Related]
12. Long-term behavioral and biochemical effects of 6-hydroxydopamine injections in rat caudate-putamen.
Cadet JL; Last R; Kostic V; Przedborski S; Jackson-Lewis V
Brain Res Bull; 1991 May; 26(5):707-13. PubMed ID: 1933391
[TBL] [Abstract][Full Text] [Related]
13. Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum.
Cenci MA; Kalén P; Mandel RJ; Wictorin K; Björklund A
Neuroscience; 1992; 46(4):943-57. PubMed ID: 1347413
[TBL] [Abstract][Full Text] [Related]
14. Reversal of behavioural abnormalities by fetal allografts in a novel rat model of striatonigral degeneration.
Wenning GK; Granata R; Laboyrie PM; Quinn NP; Jenner P; Marsden CD
Mov Disord; 1996 Sep; 11(5):522-32. PubMed ID: 8866493
[TBL] [Abstract][Full Text] [Related]
15. Ultrastructure of spared dopamine terminals in caudate-putamen nuclei of adult rats neonatally treated with intranigral 6-hydroxydopamine.
Pickel VM; Johnson E; Carson M; Chan J
Brain Res Dev Brain Res; 1992 Nov; 70(1):75-86. PubMed ID: 1361886
[TBL] [Abstract][Full Text] [Related]
16. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host.
Bentlage C; Nikkhah G; Cunningham MG; Björklund A
Exp Neurol; 1999 Sep; 159(1):177-90. PubMed ID: 10486186
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of muscarinic receptors in the rat caudate-putamen after lesioning of the ipsilateral nigrostriatal dopamine pathway with 6-hydroxydopamine (6-OHDA): normalization by fetal mesencephalic transplants.
Dawson TM; Dawson VL; Gage FH; Fisher LJ; Hunt MA; Wamsley JK
Brain Res; 1991 Feb; 540(1-2):145-52. PubMed ID: 1905173
[TBL] [Abstract][Full Text] [Related]
18. Improved graft survival and striatal reinnervation by microtransplantation of fetal nigral cell suspensions in the rat Parkinson model.
Nikkhah G; Cunningham MG; Jödicke A; Knappe U; Björklund A
Brain Res; 1994 Jan; 633(1-2):133-43. PubMed ID: 7907929
[TBL] [Abstract][Full Text] [Related]
19. Motor function, graft survival and gliosis in rats with 6-OHDA lesions and foetal ventral mesencephalic grafts chronically treated with L-dopa and carbidopa.
Blunt SB; Jenner P; Marsden CD
Exp Brain Res; 1992; 88(2):326-40. PubMed ID: 1577107
[TBL] [Abstract][Full Text] [Related]
20. Intracerebral grafting of neuronal cell suspensions. IV. Behavioural recovery in rats with unilateral 6-OHDA lesions following implantation of nigral cell suspensions in different forebrain sites.
Dunnett SB; Björklund A; Schmidt RH; Stenevi U; Iversen SD
Acta Physiol Scand Suppl; 1983; 522():29-37. PubMed ID: 6426250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
